Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element
Open Access
- 25 June 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 19 (12) , 3359-3368
- https://doi.org/10.1093/nar/19.12.3359
Abstract
All human immunodeficiency virus mRNAs contain a sequence known as TAR (trans-activating responsive sequence). The TAR element forms a stable RNA stemloop structure which binds the HIV tat (trans-activator) protein and mediates increased viral gene expression. In principle, molecules which bind to the TAR RNA structure would inhibit trans-activation by perturbing the native RNA secondary structure. We have constructed a series of phosphodiester and phosphorothioate antisense oligonucleotides which specifically bind to the HIV TAR element. Specific binding to the TAR element was demonstrated in vitro with enzymatically synthesized TAR RNA. The TAR-directed phosphorothioates inhibited trans-activation in a sequence-dependent fashion in a cell culture model using an HIV LTR/human placental alkaline phosphatase gene fusion and tat protein supplied in trans. The molecules also inhibited HIV replication in both acute and chronically infected viral assays, but without sequence specificity. We have constructed a series of vectors consisting of the MMTV promoter and 5′-untranslated region of four different mRNAs, including the TAR region, to study the effect of TAR on gene expression in heterologous systems. The results suggest that, in the absence of the HIV LTR, the TAR element has a repressive effect on gene expression, which is relieved by tat.Keywords
This publication has 43 references indexed in Scilit:
- Tat and Rev: positive regulators of HIV gene expression.1990
- Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluidJournal of Biochemical and Biophysical Methods, 1990
- Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.Proceedings of the National Academy of Sciences, 1989
- HIV TAR: An RNA enhancer?Cell, 1989
- Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.Proceedings of the National Academy of Sciences, 1989
- Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1988
- Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.Proceedings of the National Academy of Sciences, 1988
- Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1987
- Trans-activation of human immunodeficiency virus occurs via a bimodal mechanismCell, 1986
- Phosphorothioate-modified oligodeoxyribonucleotides. III. NMR and UV spectroscoptc studies of theRp-Rp,Sp-Sp, andRp-Spduplexes, [d(GGsAATTCC)]2, derived from diastereomericO-ethyl phosphorothioatesNucleic Acids Research, 1986